The store will not work correctly when cookies are disabled.
(3-chlorophenyl)(2-hydroxy-4,6-dimethoxy-3-(pyrrolidin-1-ylmethyl)phenyl)methanone
ID: ALA1093733
PubChem CID: 46884330
Max Phase: Preclinical
Molecular Formula: C20H22ClNO4
Molecular Weight: 375.85
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: COc1cc(OC)c(C(=O)c2cccc(Cl)c2)c(O)c1CN1CCCC1
Standard InChI: InChI=1S/C20H22ClNO4/c1-25-16-11-17(26-2)18(19(23)13-6-5-7-14(21)10-13)20(24)15(16)12-22-8-3-4-9-22/h5-7,10-11,24H,3-4,8-9,12H2,1-2H3
Standard InChI Key: ODEJEKFSNWXRJZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
18.0986 -9.7166 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0974 -10.5440 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8122 -10.9569 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5287 -10.5435 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5258 -9.7130 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8104 -9.3039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3826 -10.9559 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.6685 -10.5429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8080 -8.4789 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.5212 -8.0642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2438 -10.9549 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.2387 -9.2978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9547 -9.7076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2356 -8.4728 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.9545 -10.5303 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6697 -10.9400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3836 -10.5247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3778 -9.6955 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6620 -9.2895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8120 -11.7819 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0975 -12.1942 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.3444 -11.8617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7922 -12.4747 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2046 -13.1893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0115 -13.0179 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0892 -9.2778 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
12 13 1 0
1 2 2 0
12 14 2 0
2 7 1 0
13 15 2 0
3 4 2 0
15 16 1 0
7 8 1 0
16 17 2 0
17 18 1 0
6 9 1 0
18 19 2 0
19 13 1 0
4 5 1 0
3 20 1 0
9 10 1 0
20 21 1 0
21 22 1 0
2 3 1 0
4 11 1 0
5 6 2 0
5 12 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 21 1 0
6 1 1 0
18 26 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 375.85 | Molecular Weight (Monoisotopic): 375.1237 | AlogP: 3.89 | #Rotatable Bonds: 6 |
Polar Surface Area: 59.00 | Molecular Species: ACID | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 6.00 | CX Basic pKa: 7.97 | CX LogP: 3.22 | CX LogD: 3.19 |
Aromatic Rings: 2 | Heavy Atoms: 26 | QED Weighted: 0.78 | Np Likeness Score: -0.34 |
References
1. Bandgar BP, Patil SA, Totre JV, Korbad BL, Gacche RN, Hote BS, Jalde SS, Chavan HV.. (2010) Synthesis and biological evaluation of nitrogen-containing benzophenone analogues as TNF-alpha and IL-6 inhibitors with antioxidant activity., 20 (7): [PMID:20207143] [10.1016/j.bmcl.2010.02.001] |